Dr. Heike Wulff, Ph.D. founded Airmid Incorporated. Dr. Wulff is a Assistant Professor, Medical Pharmacology and Toxicology at the University of California, Davis. Dr. Wulff is the world's foremost authority on the pharmaceutical chemistry of PAP-1 and its derivatives. Dr. Wulff carried out her postdoctoral research in Dr. Chandy's laboratory at the University of California, Irvine, where she demonstrated that myelin-reactive disease-causing T cells from patients with MS exhibit a unique Kv1.3-high expression pattern. She has authored 25 peer-reviewed papers, is co-inventor on 6 patents. Dr. Wulff did PhD in Pharmaceutical Chemistry from the University of Kiel, Germany.
+44 1478 350008